Advisor Group Inc. Decreases Position in Nu Skin Enterprises, Inc. (NUS)

Advisor Group Inc. trimmed its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 4.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,712 shares of the company’s stock after selling 279 shares during the period. Advisor Group Inc.’s holdings in Nu Skin Enterprises were worth $360,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in shares of Nu Skin Enterprises by 0.4% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 7,249 shares of the company’s stock valued at $456,000 after buying an additional 31 shares in the last quarter. US Bancorp DE raised its holdings in shares of Nu Skin Enterprises by 3.3% during the 2nd quarter. US Bancorp DE now owns 2,032 shares of the company’s stock valued at $128,000 after buying an additional 65 shares in the last quarter. Loudon Investment Management LLC raised its holdings in shares of Nu Skin Enterprises by 1.2% during the 2nd quarter. Loudon Investment Management LLC now owns 8,675 shares of the company’s stock valued at $545,000 after buying an additional 100 shares in the last quarter. Capstone Asset Management Co. raised its holdings in shares of Nu Skin Enterprises by 2.3% during the 2nd quarter. Capstone Asset Management Co. now owns 4,989 shares of the company’s stock valued at $314,000 after buying an additional 110 shares in the last quarter. Finally, Retirement Systems of Alabama raised its holdings in shares of Nu Skin Enterprises by 0.4% during the 2nd quarter. Retirement Systems of Alabama now owns 64,033 shares of the company’s stock valued at $4,024,000 after buying an additional 237 shares in the last quarter. 79.25% of the stock is currently owned by institutional investors.

A number of brokerages recently weighed in on NUS. Zacks Investment Research cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. TheStreet raised Nu Skin Enterprises from a “c+” rating to a “b” rating in a report on Wednesday, August 2nd. BidaskClub cut Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Bank of America Corporation raised their price objective on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a report on Monday, July 10th. Finally, Deutsche Bank AG raised their price objective on Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a report on Wednesday, June 21st. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $62.00.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $60.88, for a total transaction of $456,600.00. Following the sale, the general counsel now directly owns 52,230 shares in the company, valued at $3,179,762.40. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Daniel W. Campbell sold 4,607 shares of the company’s stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $62.48, for a total value of $287,845.36. Following the sale, the director now owns 63,753 shares in the company, valued at $3,983,287.44. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,107 shares of company stock worth $1,264,445. Company insiders own 5.20% of the company’s stock.

Nu Skin Enterprises, Inc. (NUS) opened at 63.17 on Wednesday. The company’s 50-day moving average price is $61.31 and its 200 day moving average price is $59.16. The company has a market capitalization of $3.34 billion, a price-to-earnings ratio of 21.13 and a beta of 1.40. Nu Skin Enterprises, Inc. has a 52-week low of $46.35 and a 52-week high of $65.85.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.08. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. The business had revenue of $550.10 million for the quarter, compared to the consensus estimate of $548.09 million. During the same period in the prior year, the business posted $0.79 earnings per share. The company’s quarterly revenue was down 8.4% compared to the same quarter last year. On average, equities analysts expect that Nu Skin Enterprises, Inc. will post $3.23 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 13th. Shareholders of record on Friday, August 25th were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Wednesday, August 23rd. This represents a $1.44 dividend on an annualized basis and a yield of 2.28%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 48.81%.

COPYRIGHT VIOLATION WARNING: This piece of content was published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at https://sportsperspectives.com/2017/10/11/advisor-group-inc-decreases-position-in-nu-skin-enterprises-inc-nus.html.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply